FIELD: medicine, cardiology.
SUBSTANCE: in addition to conventional therapy at applying β-adrenoblockers, APF inhibitors, diuretics, aldosterone inhibitors prescribed for patients depending upon the stage of CHF functional class and concomitant diseases it is necessary to introduce Mexicor at the dosage of 0.1 thrice daily for 3 mo. The innovation in question provides efficient therapy due to increased diastolic reserve of left ventricle.
EFFECT: higher efficiency of therapy.
3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING PATIENTS WITH CHRONIC HEART FAILURE AT THE BACKGROUND OF ISCHEMIC CARDIAC DISEASE | 2000 |
|
RU2213559C2 |
| METHOD FOR REHABILITATION OF ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASES ACCOMPANIED BY CHRONIC HEART INSUFFICIENCY FOLLOWING MYOCARDIAL INFARCTION | 2014 |
|
RU2554756C1 |
| METHOD FOR DETERMINING INDICATIONS TO SURGICAL TREATMENT OF CARDIAC ISCHEMIA PATIENTS SURVIVED AFTER MYOCARDIAL INFARCTION | 2004 |
|
RU2269934C1 |
| METHOD OF COMPLEX IMMUNOMODULATING TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION | 2010 |
|
RU2422136C1 |
| METHOD FOR PREDICTION OF MEDICAL-SOCIAL EFFECTIVENESS OF INTEGRATED TREATMENT IN PATIENTS WITH ARTERIAL HYPERTENSION | 2012 |
|
RU2522389C1 |
| METHOD OF COMPLEX IMMUNOMODULATING TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE | 2010 |
|
RU2428980C1 |
| METHOD OF DIFFERENTIAL PRESCRIPTION OF β-ADRENORECEPTOR BLOCKING AGENTS IN PATIENTS WITH CHRONIC CARDIAC FAILURE | 2010 |
|
RU2454998C1 |
| METHOD FOR THE TREATMENT OF CHRONIC HEART FAILURE IN YOUNG CHILDREN WITH A DILATED PHENOTYPE OF CARDIOMYOPATHY | 2021 |
|
RU2768596C1 |
| METHOD OF TREATING PATIENTS SUFFERING CHRONIC CARDIAC FAILURE COMPROMISED TYPE 2 DIABETES | 2010 |
|
RU2421218C1 |
| METHOD OF RISK EVALUATION OF PERIOPERATIVE CARDIOVASCULAR COMPLICATIONS IN EXTRACARDIAC SURGERIES | 2009 |
|
RU2410017C1 |
